| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| MIDOSTAURIN (has an active metabolite)
| MIDOSTAURIN | ANTINEOPLASTIC | ORAL | Tmax 2 HOUR VD 95.2 LITER PPB 99.8 PERCENT HT 21 HOUR | FLT3 KINASE FLT3 MUTANT KINASES KIT PDGFR VEGFR2 SERINE/THREONINE KINASE PKC PDB 4NCT (HUMAN DYRK1A IN COMPLEX WITH PKC412) LIGAND CODE = 2K2 (link to the list of PDB complexes) Download experimental 3D coordinates of 2K2 with added hydrogens | Receptor-type tyrosine-protein kinase FLT3 UNIPROT P36888 FLT3 more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M MIDOSTAURIN (is an active metabolite)
| MIDOSTAURIN | ANTINEOPLASTIC | - | PPB 99.8 PERCENT HT 32 HOUR | FLT3 KINASE FLT3 MUTANT KINASES KIT PDGFR VEGFR2 SERINE/THREONINE KINASE PKC | Receptor-type tyrosine-protein kinase FLT3 UNIPROT P36888 FLT3 more at DrugCentral | EMA | |||
| 3 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M MIDOSTAURIN (is an active metabolite)
| MIDOSTAURIN | ANTINEOPLASTIC | - | PPB 99.8 PERCENT HT 482 HOUR | FLT3 KINASE FLT3 MUTANT KINASES KIT PDGFR VEGFR2 SERINE/THREONINE KINASE PKC | Receptor-type tyrosine-protein kinase FLT3 UNIPROT P36888 FLT3 more at DrugCentral | EMA | |||
| 4 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M MIDOSTAURIN (is an active metabolite)
| MIDOSTAURIN | ANTINEOPLASTIC | - | PPB 99.8 PERCENT HT 482 HOUR | FLT3 KINASE FLT3 MUTANT KINASES KIT PDGFR VEGFR2 SERINE/THREONINE KINASE PKC | Receptor-type tyrosine-protein kinase FLT3 UNIPROT P36888 FLT3 more at DrugCentral | EMA | |||
